Parabilis starts dose-ranging FAP study of zolucatetide
Go back to Parabilis starts dose-ranging FAP study of zolucatetide| Phoenix Assoc Land Syndicate (NASDAQ: PBLS) | Delayed: 25.89 -0.96 (3.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.85 | 52 Week High | $0.00 | |||
| Open | $27.00 | 52 Week Low | $0.00 | |||
| Day High | $27.39 | P/E | N/A | |||
| Day Low | $25.73 | EPS | $0.00 | |||
| Volume | 762,254 | |||||



